Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
2013 · American Journal of Psychiatry · 1,186 citations
https://doi.org/10.1176/appi.ajp.2013.13030392
J
James W. Murrough
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
278
Papers
22.1K
Citations
71
h-index
149
i10-index
James W. Murrough is an academic researcher from Nathan Kline Institute for Psychiatric Research. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Functional Brain Connectivity Studies. The author has an h-index of 71, co-authored 237 publications.
ORCID: 0000-0001-6286-1242Papers by this author
worksNeurobiology of resilience
2012 · Nature Neuroscience · 1,169 citations
https://doi.org/10.1038/nn.3234
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
2021 · American Journal of Psychiatry · 647 citations
https://doi.org/10.1176/appi.ajp.2020.20081251
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
2023 · World Psychiatry · 556 citations
https://doi.org/10.1002/wps.21120
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
2014 · Biological Psychiatry · 474 citations
https://doi.org/10.1016/j.biopsych.2014.03.026
Targeting glutamate signalling in depression: progress and prospects
2017 · Nature Reviews Drug Discovery · 473 citations
https://doi.org/10.1038/nrd.2017.16
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat